Literature DB >> 16585603

A severe form of human combined immunodeficiency due to mutations in DNA ligase IV.

Anselm Enders1, Paul Fisch, Klaus Schwarz, Ulrich Duffner, Ulrich Pannicke, Elisabeth Nikolopoulos, Anke Peters, Marzenna Orlowska-Volk, Detlev Schindler, Wilhelm Friedrich, Barbara Selle, Charlotte Niemeyer, Stephan Ehl.   

Abstract

DNA ligase IV (LigIV) deficiency was identified as the molecular basis for a severe form of combined immunodeficiency in two microcephalic siblings with cellular radiosensitivity. In one patient the diagnosis was made directly after birth, allowing analysis of the role of LigIV in the development of specific immune cells. Absolute numbers of B cells were reduced 100-fold and alphabeta T cells 10-fold, whereas gammadelta T cells were normal. Spectratyping of all three cell populations showed a diverse repertoire, but sequencing of IgH V(D)J junctions revealed shorter CDR3 regions due to more extensive nucleotide deletions among D and J elements and fewer N nucleotide insertions. Clonal restriction of IgG-expressing, but not IgM-expressing, B cells and the lack of primary and secondary lymph node follicles indicated impaired class switch recombination. Observations in the older sibling showed that this rudimentary immune system was able to mount specific responses to infection. However, partial Ab responses and extensive amplification of gammadelta T cells could not prevent a life-threatening course of viral and bacterial infections, the development of an EBV-induced lymphoma, and immune dysregulation reflected by severe autoimmune cytopenia. Impaired generation of immune diversity under conditions of limited LigIV activity can cause a human SCID variant with a characteristic immunological phenotype.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16585603     DOI: 10.4049/jimmunol.176.8.5060

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  46 in total

1.  Evaluation of Severe Combined Immunodeficiency and Combined Immunodeficiency Pediatric Patients on the Basis of Cellular Radiosensitivity.

Authors:  Pavel Lobachevsky; Lisa Woodbine; Kuang-Chih Hsiao; Sharon Choo; Chris Fraser; Paul Gray; Jai Smith; Nickala Best; Laura Munforte; Elena Korneeva; Roger F Martin; Penny A Jeggo; Olga A Martin
Journal:  J Mol Diagn       Date:  2015-07-04       Impact factor: 5.568

Review 2.  Clinical radiation sensitivity with DNA repair disorders: an overview.

Authors:  Julianne M Pollard; Richard A Gatti
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-08-01       Impact factor: 7.038

Review 3.  Stem cell transplantation for primary immunodeficiency diseases: the North American experience.

Authors:  Sung-Yun Pai; Morton J Cowan
Journal:  Curr Opin Allergy Clin Immunol       Date:  2014-12

Review 4.  B-cell receptor repertoire sequencing in patients with primary immunodeficiency: a review.

Authors:  Marie Ghraichy; Jacob D Galson; Dominic F Kelly; Johannes Trück
Journal:  Immunology       Date:  2017-12-18       Impact factor: 7.397

5.  Ligase-4 Deficiency Causes Distinctive Immune Abnormalities in Asymptomatic Individuals.

Authors:  Kerstin Felgentreff; Sachin N Baxi; Yu Nee Lee; Kerry Dobbs; Lauren A Henderson; Krisztian Csomos; Erdyni N Tsitsikov; Mary Armanios; Jolan E Walter; Luigi D Notarangelo
Journal:  J Clin Immunol       Date:  2016-04-11       Impact factor: 8.317

6.  T-B+NK+ severe combined immunodeficiency caused by complete deficiency of the CD3zeta subunit of the T-cell antigen receptor complex.

Authors:  Joseph L Roberts; Jens Peter H Lauritsen; Myriah Cooney; Roberta E Parrott; Elisa O Sajaroff; Chan M Win; Michael D Keller; Jeffery H Carpenter; Juan Carabana; Michael S Krangel; Marcella Sarzotti; Xiao-Ping Zhong; David L Wiest; Rebecca H Buckley
Journal:  Blood       Date:  2006-12-14       Impact factor: 22.113

7.  Chronic inflammatory bowel disease as key manifestation of atypical ARTEMIS deficiency.

Authors:  Jan Rohr; Ulrich Pannicke; Michaela Döring; Annette Schmitt-Graeff; Elisabeth Wiech; Andreas Busch; Carsten Speckmann; Ingo Müller; Peter Lang; Rupert Handgretinger; Paul Fisch; Klaus Schwarz; Stephan Ehl
Journal:  J Clin Immunol       Date:  2009-12-05       Impact factor: 8.317

Review 8.  Pathogenesis of ataxia-telangiectasia: the next generation of ATM functions.

Authors:  Mark Ambrose; Richard A Gatti
Journal:  Blood       Date:  2013-02-25       Impact factor: 22.113

9.  Impaired lymphocyte development and antibody class switching and increased malignancy in a murine model of DNA ligase IV syndrome.

Authors:  Anastasia Nijnik; Sara Dawson; Tanya L Crockford; Lisa Woodbine; Supawan Visetnoi; Sophia Bennett; Margaret Jones; Gareth D Turner; Penelope A Jeggo; Christopher C Goodnow; Richard J Cornall
Journal:  J Clin Invest       Date:  2009-05-18       Impact factor: 14.808

Review 10.  Non-homologous end joining in class switch recombination: the beginning of the end.

Authors:  Ashwin Kotnis; Likun Du; Chonghai Liu; Sergey W Popov; Qiang Pan-Hammarström
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2009-03-12       Impact factor: 6.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.